Larry Gold

Dr. Larry Gold is the Founder of Clipper Bio. He is also Founder, Chairman of the Board, and Past CEO of SomaLogic. He also founded NeXagen, Inc., which later became NeXstar Pharmaceuticals, Inc. In 1999, NeXstar merged with Gilead Sciences, Inc. to form a global organization committed to the discovery, development and commercialization of novel products that treat infectious diseases. Before forming NeXagen, he co-founded and served as co-director of research at Synergen, Inc., a biotechnology company later acquired by Amgen, Inc. He also founded Ten Zero Therapeutics, a pain management company.

Dr. Gold also established the GoldLab Symposia in 2010, an annual event that tackles big questions in healthcare (www.goldlabfoundation.org). Inspired by conversations through the GoldLab Symposia, he founded The Colorado Longitudinal Study (COLS), a Rare Disease Initiative (RDI) that is determined to create the world’s most thorough and largest longitudinal or long-term biobank. Dr. Gold is determined to change healthcare for the better through teaching, research, and debate among scientists and citizens throughout the world.

Since 1970, Dr. Gold has been a professor at the University of Colorado at Boulder. While at the university, he served as the chairman of the Molecular, Cellular and Developmental Biology Department from 1988 to 1992. Dr. Gold has received many citations including the CU Distinguished Lectureship Award, the National Institutes of Health Merit Award, the Career Development Award, and the Chiron Prize for Biotechnology.